Lenskart widens eyewear lead as revenue, margins and store expansion outpace Titan EyeCare, resurfacing a December filing
Resurfacing figures from a December 2025 disclosure: Lenskart added 203 net new India stores in H1 FY26, expanded to 431 cities and lifted Q2 revenue 24% year on year to Rs 2,146.6 crore. Titan EyeCare’s domestic income grew, but segment EBIT fell 50% to Rs 12 crore, underscoring diverging momentum in India’s eyewear market.
What happened
Lenskart is scaling India eyewear through AI-led site selection, remote tests, fast delivery and local manufacturing, while Titan EyeCare focuses on optometry
Key facts
- Lenskart listed at Rs 390 versus Rs 402 issue price
- Lenskart added 203 net new India stores in H1 FY26 and reached 431 cities
- Lenskart conducted 9.3 million India eye tests in H1 FY26; 46% were first-time users
- Lenskart Q2 FY26 revenue rose 24% YoY to Rs 2,146.6 crore; EBITDA was Rs 425.8 crore and margin 19.8%
- Lenskart H1 FY26 EBITDA margin rose to 19.5% from 17.3%
- Titan EyeCare had 871 exclusive stores as of September 2025
- Titan EyeCare domestic income rose to Rs 215 crore from Rs 199 crore; EBIT fell to Rs 12 crore from Rs 24 crore
- Lenskart product margin was 69.2%; local frame production provides a stated 35%-40% cost advantage
Why this matters
Lenskart’s scale-up creates a stronger case for acquiring or partnering with regional optical chains, diagnostic providers and digital vision-care platforms to accelerate reach and customer lifetime value.
What to watch
- Lenskart quarterly same-store sales growth, net store additions, city expansion pace and whether EBITDA margin remains above 19%.
- Titan EyeCare’s next two quarters of EBIT margin, domestic income growth, store closures/openings and commentary on discounting or inventory clearance.
- Evidence of promotional intensity: buy-one-get-one offers, free eye-test campaigns, lens bundling and online price gaps versus in-store pricing.
- Store productivity indicators, including revenue per store, payback periods, mall versus high-street mix and optometrist staffing availability.
- Market-share shifts in prescription eyewear, especially in Tier-2/3 cities and value-priced frames/lenses.
- Changes in eyewear import costs, frame/lens sourcing, commercial rents and consumer discretionary spending that could challenge margin expansion.
- Lenskart is likely to sustain dense expansion in Tier-2 and Tier-3 cities, using clusters of stores to improve local fulfillment and brand visibility.
- Lenskart may increase private-label and vertically integrated lens/frame mix to defend its 19.5% EBITDA margin while offering sharper entry-price promotions.
- Titan EyeCare is likely to emphasize store productivity, premium assortment, Titan brand cross-selling and selective network optimization before materially accelerating new-store openings.
- Both players may invest more in eye-test-led customer acquisition, CRM-driven repeat purchases, faster prescription fulfillment and omnichannel appointment journeys.
- Independent opticians may face greater pressure to affiliate with buying groups, specialize in premium service, or compete through localized relationships and faster customization.